Skip to main content

Table 2 CMR ventricular function in pulmonary hypertension and healthy control groups

From: Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension

Variables PAH (n = 42) Healthy Controls (n = 11) p-value
LVEF (%), median (range) 70 (46–86) 69 (51–75) 0.875
LV EDVI (ml/m2), median (range) 70 (44–112) 65 (45–81) 0.302
LV ESVI (ml/m2), median (range) 21 (7–52) 20 (13–28) 0.645
LV mass index (g/m2), median (range) 51 (36–72) 48 (39–68) 0.280
LV SV index (ml/m2), median (range) 46 (32–71) 45 (29–58) 0.428
RVEF (%), median (range) 61 (45–79) 63 (50–79) 0.304
RV EDVI (ml/m2), median (range) 60 (30–111) 60 (47–89) 0.972
RV ESVI (ml/m2), median (range) 22 (12–61) 22 (10–41) 0.823
RV SV Index (ml/m2), median (range) 37 (15–60) 38 (27–54) 0.595
RV ED Mass Index (g/m2), median (range) 17 (9–42) 13 (9–19) 0.001
RV (ED) mass/volume ratio, median (range) 0.30 (0.22–0.49) 0.22 (0.15–0.25)  < 0.001
RV inferior wall thickness (mm), median (range) 4 (3–9) 3 (2–5) 0.002
  1. CMR cardiovascular magnetic resonance, LV left ventricle, RV right ventricle, EF ejection fraction, EDVI end-diastolic volume index, ESVI end-systolic volume index, ED end-diastolic, SV stroke volume